Drug Profile
Research programme: bipolar disorder therapies - Psychiatric Genomics
Alternative Names: PGX 5188Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Psychiatric Genomics
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Bipolar disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Bipolar-disorders in USA
- 24 Mar 2004 Preclinical trials in Bipolar disorders in USA (unspecified route)